Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
0.5074
+0.0252 (5.22%)
Jun 27, 2025, 1:47 PM - Market open
Ainos Revenue
Ainos had revenue of $106.21K in the quarter ending March 31, 2025, with 412.36% growth. This brings the company's revenue in the last twelve months to $106.21K, up 13.38% year-over-year. In the year 2024, Ainos had annual revenue of $20.73K, down -83.02%.
Revenue (ttm)
$106.21K
Revenue Growth
+13.38%
P/S Ratio
54.60
Revenue / Employee
$2,414
Employees
44
Market Cap
10.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.73K | -101.38K | -83.02% |
| Dec 31, 2023 | 122.11K | -3.40M | -96.53% |
| Dec 31, 2022 | 3.52M | 2.93M | 491.97% |
| Dec 31, 2021 | 594.56K | 578.00K | 3,489.71% |
| Dec 31, 2020 | 16.56K | 4.83K | 41.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
AIMD News
- 6 hours ago - Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites - Accesswire
- 1 day ago - Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation - Accesswire
- 3 days ago - Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia - Accesswire
- 10 days ago - Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25 - Accesswire
- 11 days ago - Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy - Accesswire
- 24 days ago - Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter - Accesswire
- 4 weeks ago - Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80% - Accesswire
- 5 weeks ago - Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner - Accesswire